Not a good buy right now for an impatient entry: price is still trading below the key pivot (25.715) with bearish momentum signals (MACD < 0).
Setup is “early bottoming” at best (RSI ~37 and MACD bearish but improving), but there’s no catalyst/news flow to force a reversal immediately.
Options positioning is moderately bullish (low put/call OI), yet options activity is light vs recent averages—supportive, not decisive.
Best tactical trigger for a buy would be either: (1) a clean reclaim of 25.715 (pivot) to confirm trend shift, or (2) a pullback closer to 23.123 support for a tighter-risk entry. As of now, the risk/reward is not compelling enough to chase.
Technical Analysis
Trend/Momentum: MACD histogram at -0.628 (below zero) but negatively contracting → bearish trend is weakening, not reversed.
RSI: RSI_6 at 37.346 → mildly oversold/weak, but not a strong reversal signal on its own.
Moving averages: Converging MAs → consolidation/base-building behavior; direction still unconfirmed.
Net income: 256,173,000 (-464.11% YoY) → sharp decline (suggests prior-year base effects and/or margin/other income headwinds).
EPS: 1.79 (-431.48% YoY) → earnings power trending down YoY.
Gross margin: 42.1 (-11.81% YoY) → weakening unit economics; the market often punishes growth with falling margins.
Trading flows: Hedge funds neutral (no significant quarterly trend); insiders neutral (no significant monthly trend).
Congress trading (last 90 days): no recent data available.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
[2025-11-24] CICC initiated coverage with Outperform and a $23.50 price target.
Trend/takeaway: only a single initiation is provided (no upgrades/downgrades series), so the Street view is limited in this dataset.
Wall Street pros: Outperform rating implies expectation of relative upside.
Wall Street cons: the cited $23.50 target is below the current price (~$24.23), which is a practical bearish constraint for near-term upside expectations.
Wall Street analysts forecast HSAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSAI is 29.9 USD with a low forecast of 26.7 USD and a high forecast of 33 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast HSAI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HSAI is 29.9 USD with a low forecast of 26.7 USD and a high forecast of 33 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 24.090
Low
26.7
Averages
29.9
High
33
Current: 24.090
Low
26.7
Averages
29.9
High
33
CICC
NULL -> Outperform
initiated
$23.50
AI Analysis
2025-11-24
Reason
CICC
Price Target
$23.50
AI Analysis
2025-11-24
initiated
NULL -> Outperform
Reason
CICC initiated coverage of Hesai with an Outperform rating and $23.50 price target.
Goldman Sachs
Tina Hou
Buy
maintain
$36
2025-09-22
Reason
Goldman Sachs
Tina Hou
Price Target
$36
2025-09-22
maintain
Buy
Reason
Goldman Sachs analyst Tina Hou raised the firm's price target on Hesai to $36 from $26.30 and keeps a Buy rating on the shares. The firm sees LiDAR adoption ramping in China this year with global adoption ramping in 2026 and 2027. By 2030, Hesai's overseas advanced driver assistance systems LiDAR volume should reach 3M, exluding the U.S., similar to China's volume in 2025, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HSAI
